Who are Atrovent + Bricanyl or Atrovent + Ventoline's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Duovent HFA, Ipratropium/albuterol, Ipratropium + Levosalbutamol Free Dose Combination.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/atrovent-bricanyl-or-atrovent-ventoline.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Atrovent + Bricanyl or Atrovent + Ventoline — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Atrovent + Bricanyl or Atrovent + Ventoline (Atrovent + Bricanyl or Atrovent + Ventoline) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination bronchodilator (anticholinergic + beta-2 agonist). Area: Respiratory/Pulmonology.

marketed Combination bronchodilator (anticholinergic + beta-2 agonist) Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptor Respiratory/Pulmonology Small molecule Live · refreshed every 30 min

Target snapshot

Atrovent + Bricanyl or Atrovent + Ventoline (Atrovent + Bricanyl or Atrovent + Ventoline) — University Hospital, Tours. This combination pairs an anticholinergic bronchodilator with a beta-2 agonist bronchodilator to relax airway smooth muscle through dual pathways.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Atrovent + Bricanyl or Atrovent + Ventoline TARGET	Atrovent + Bricanyl or Atrovent + Ventoline	University Hospital, Tours	marketed	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptor
Duovent HFA	Duovent HFA	Centre Hospitalier Universitaire UCLouvain Namur	marketed	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptors
Ipratropium/albuterol	Ipratropium/albuterol	National Jewish Health	marketed	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (ipratropium); beta-2 adrenergic receptor (albuterol)
Ipratropium + Levosalbutamol Free Dose Combination	Ipratropium + Levosalbutamol Free Dose Combination	Neutec Ar-Ge San ve Tic A.Ş	phase 3	Combination bronchodilator (anticholinergic + beta-2 agonist)	Muscarinic acetylcholine receptors (M3) and beta-2 adrenergic receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination bronchodilator (anticholinergic + beta-2 agonist) class)

Centre Hospitalier Universitaire UCLouvain Namur · 1 drug in this class
National Jewish Health · 1 drug in this class
Neutec Ar-Ge San ve Tic A.Ş · 1 drug in this class
University Hospital, Tours · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Atrovent + Bricanyl or Atrovent + Ventoline — Competitive Intelligence Brief. https://druglandscape.com/ci/atrovent-bricanyl-or-atrovent-ventoline. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab